Therapeutic classes
Pharmacist Interventions n (%) Pharmacist Interventions n (%) Pharmacist Interventions n (%)
Prior to COVID-19 (n=54) During COVID-19 (n=177) p-value
Acetaminophen
6 (11.1%) 5 (9.3%)
31 (17.5%)
0.298
Anticoagulants 17 (9.6%) 1.000
Anti-depressors 0 2 (1.1%) 1.000
Antidiabetics 1 (1.9%) 2 (1.1%) 0.552
Antiemetics 1 (1.9%) 0 0.234
Anti-histamine 0 1 (0.6%) 1.000
Anti-infectious 4 (7.4%) 36 (20.3%) 0.038
Anti inflammatories 2 (3.7%) 4 (2.3%) 0.626
Anti-parkinsonians 0 1 (0.6%) 1.000
Anti-platelets 3 (5.6%) 9 (5.1%) 1.000
Cardiologic drugs 0 6 (3.4%) 0.340
Experimental drugs 0 1 (0.6%) 1.000
Laxatives 7 (13.0%) 7 (4.0%) 0.023
Lipid lowering drugs 4 (7.4%) 6 (3.4%) 0.249
Ophthalmic drugs 2 (3.7%) 4 (2.3%) 0.626
Opioids 2 (3.7%) 11 (6.2%) 0.738
Proton pump inhibitor 6 (11.1%) 16 (9.0%) 0.606
Psycholeptics 3 (5.6%) 2 (1.1%) 0.085
Respiratory system drugs 0 2 (1.1%) 1.000
Supplements 5 (9.3%) 13 (7.3%) 0.772
Urological agents 3 (5.6%) 6 (3.4%) 0.440